SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-24-005898
Filing Date
2024-04-26
Accepted
2024-04-26 16:05:19
Documents
6
Period of Report
2024-06-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20240613xdef14a.htm DEF 14A 665481
2 GRAPHIC tmb-20240613xdef14a_a001.jpg GRAPHIC 10189
3 GRAPHIC tmb-20240613xdef14a_a011.jpg GRAPHIC 51798
4 GRAPHIC tmb-20240613xdef14a_a012.jpg GRAPHIC 46541
5 GRAPHIC tmb-20240613xdef14a_bg001.jpg GRAPHIC 181964
6 GRAPHIC tmb-20240613xdef14a_bg002.jpg GRAPHIC 154348
  Complete submission text file 0001558370-24-005898.txt   1279838
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37719 | Film No.: 24883530
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)